Minimally Invasive Surgical Repair of Simple Congenital Heart Defects Using the Right Vertical Infra-Axillary Thoracotomy Approach
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2024
DOI: 10.1177/15569845241273650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2024. Verfasst von Dien Minh Tran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical ICU, Vietnam National Children's Hospital, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Thoracotomy, Minimally Invasive Surgical Procedures, Heart Defects, Congenital. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the safety and efficacy of surgical repair for patients diagnosed with simple congenital heart defects (CHD) using the minimally invasive right vertical infra-axillary minithoracotomy (RVIAT) approach.
Methods
We retrospectively reviewed the clinical data of consecutive patients who underwent minimally invasive RVIAT for repair of CHD between August 2019 and August 2022. There were 382 patients who underwent 8 primary procedures and were included in this study.
Results
The median age of the patients was 16.2 (interquartile range [IQR], 7.2 to 41.9) months, and the median weight of the patients was 8.8 (IQR, 6.5 to 14) kg. The preoperative diagnoses were as follows: ventricular septal defect, atrial septal defect, partial anomalous pulmonary venous return, partial atrioventricular septal defect, cor triatriatum, complete atrioventricular septal defect, and myxoma. The mean aortic cross-clamp time, bypass time, and operation time were 45.4 ± 19.3 min, 65.6 ± 23.1 min, and 154.5 ± 29.7 min, respectively. There was no in-hospital mortality or conversion to median sternotomy. Two patients (0.5%) required early reoperation; 1 due to postoperative bleeding and 1 for permanent pacemaker implantation. Other complications included trivial residual shunts (23 of 382, 6%), pleural effusion (3 of 382, 0.8%), pneumothorax (0.8%), and wound infection (4 of 382, 1%). There were 2 late noncardiac deaths. Late reoperation was performed on 1 patient with progressive aortic valve regurgitation who required aortic valvuloplasty.
Conclusions
RVIAT is a minimally invasive approach that can be safely performed on patients with simple CHDs. RVIAT may be a good alternative approach for median sternotomy and cardiac intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical ICU, Vietnam National Children's Hospital, Hanoi, Vietnam.
- Department of Cardiovascular Surgery, Heart Center, Vietnam National Children's Hospital, Hanoi, Vietnam.
- Department of Cardiovascular Surgery, Okayama University Hospital, Japan.
ORCID-Profile: Truong Ly-Thinh Nguyen
Zitieren
APA
Tran, D. M., Tran, V. Q., Nguyen, M. T., Mai, D. D., Doan, A. V., Hoang, S. T., Kotani, Y., & Nguyen, T. L. (2024). Minimally Invasive Surgical Repair of Simple Congenital Heart Defects Using the Right Vertical Infra-Axillary Thoracotomy Approach. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. https://doi.org/10.1177/15569845241273650
Vancouver
Tran DM, Tran VQ, Nguyen MT, Mai DD, Doan AV, Hoang ST, et al. Minimally Invasive Surgical Repair of Simple Congenital Heart Defects Using the Right Vertical Infra-Axillary Thoracotomy Approach. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2024. doi:10.1177/15569845241273650
BibTeX
@article{Tran2024,
author = {Tran, Dien Minh and Tran, Vinh Quang and Nguyen, Mai Tuan and Mai, Duyen Dinh and Doan, Anh Vuong and Hoang, Son Thanh and Kotani, Yasuhiro and Nguyen, Truong Ly-Thinh},
title = {Minimally Invasive Surgical Repair of Simple Congenital Heart Defects Using the Right Vertical Infra-Axillary Thoracotomy Approach},
journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
year = {2024},
doi = {10.1177/15569845241273650}
}
EUVIMED